SCHEMBL19148973

SCHEMBL19148973

COc1ccc2nc(C(F)F)cc(C(F)F)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.43
▸ POLB P06746 4/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ DYRK3 O43781 1/20 0.43
▸ CLK1 P49759 1/20 0.43
▸ CLK2 P49760 1/20 0.43
▸ CLK3 P49761 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ DYRK1A Q13627 1/20 0.43
▸ HASPIN Q8TF76 1/20 0.43
▸ DYRK2 Q92630 1/20 0.43
▸ CLK4 Q9HAZ1 1/20 0.43
▸ DYRK4 Q9NR20 1/20 0.43
▸ DYRK1B Q9Y463 1/20 0.43
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ NQO2 P16083 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19148598 0.88 KDM4E (0.41) KDM4EPOLBHSD17B10LMNADYRK3
SCHEMBL19148196 0.82 DHODH (0.42) KDM4EHSD17B10LMNADYRK1ASMN1; SMN2
SCHEMBL19150076 0.81 NT5E (0.54) KDM4EPOLBHSD17B10LMNACLK1
SCHEMBL19150073 0.77 DHODH (0.37) KDM4EALDH1A1GAABCHEACHE
SCHEMBL19148957 0.75 PDE3B (0.43) KDM4EAPP
SCHEMBL19148954 0.73 CCNE2 (0.41) KDM4E
SCHEMBL3291837 0.73 TDP1 (0.43) KDM4EPOLBHSD17B10LMNAKMT2A
SCHEMBL31391548 0.71 POLB (0.46) KDM4EPOLBHSD17B10LMNADYRK3
SCHEMBL23717032 0.70 KDM4E (0.57) KDM4EPOLBHSD17B10LMNAMEN1
SCHEMBL24915973 0.70 POLB (0.57) KDM4EPOLBHSD17B10LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-04-23 — — US disclosed
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2019-01-24 — — US disclosed
EP-3405458-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES Bayer CropScience Aktiengesellschaft (DE) 2018-11-28 — — EP disclosed
WO-2017125318-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-07-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023659-A1 PROCESS FOR THE PREPARATION OF POLYFLUOROALKYLATED QUINOLINES KCNQ1, KCNQ2, KCNQ4 KDM4E 420/4885POLB 605/4885HSD17B10 4446/4885
US-10266494-B2 Process for the preparation of polyfluoroalkylated quinolines KCNQ1, KCNQ2, KCNQ4 KDM4E 420/4885POLB 605/4885HSD17B10 4446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback